Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,739,587
+$78,606 QoQ
Shares Held
18,662
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#1,659
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ausdal Financial Partners, Inc. holds $34,343,984 across 14 Drug Manufacturers - General names. JNJ ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,231 | $9,872,508 | |
| 2 | ABBV |
AbbVie Inc.
|
39,096 | $9,838,116 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
18,662 | $4,739,587 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,933 | $3,075,390 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,985 | $2,019,544 | |
| 6 | AMGN |
Amgen Inc
|
2,893 | $1,047,612 | |
| 7 | PFE |
Pfizer Inc
|
41,679 | $1,003,629 | |
| 8 | NVS |
Novartis AG
|
4,509 | $706,649 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,739,587 | 18,662 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $4,660,981 | 19,068 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $3,432,886 | 16,588 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,087,242 | 16,650 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,989,568 | 13,025 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,276,319 | 13,726 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,421,325 | 9,828 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,507,320 | 9,301 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $1,411,028 | 9,654 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,537,132 | 9,717 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,557,055 | 9,934 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $1,600,642 | 10,277 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,948,501 | 11,772 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,893,945 | 12,219 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,225,613 | 12,599 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,969,631 | 12,057 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,141,835 | 12,066 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,182,941 | 12,317 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,120,070 | 12,393 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,978,375 | 12,250 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $2,006,533 | 12,180 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $2,246,171 | 13,667 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $2,219,372 | 14,102 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $1,933,802 | 12,989 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $1,903,567 | 13,536 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,802,512 | 13,746 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||